Teva Pharmaceutical Industries Ltd. ADR

NYS: TEVA

GO
/marketstate/country/us

Market open

/zigman2/quotes/205657894/composite

$

8.66

Change

-0.21 -2.37%

Volume

Volume 3.53m

Nov 28, 2022, 1:34 p.m.

Real time quotes

/zigman2/quotes/205657894/composite

Previous close

$ 8.87

$ 8.66

Change

-0.21 -2.37%

Day low

Day high

$8.61

$8.85

Open
Open: 8.73

52 week low

52 week high

$6.78

$11.34

Open

Market cap

$9.75B

Average volume

9.20M

P/E ratio

N/A

Rev. per Employee

$401,923

EPS

-1.17

Dividend

N/A

Div yield

N/A

Ex dividend date

N/A

Compare:
Indexes
  • Dow(INDU) INDU
  • Nasdaq (COMP) COMP
  • S&P 500 (SPX) SPX
  • Global Dow (GDOW) GDOW
1d
5d
3m
6m
1y
3y
5y
/news/latest/company/us/teva

MarketWatch News on TEVA

  1. Teva names former Sandoz chief Richard Francis as new CEO

    7:16 a.m. Nov. 21, 2022

    - Steve Gelsi

  2. Teva Pharmaceutical names pharma exec Richard Francis and president and CEO

    7:05 a.m. Nov. 21, 2022

    - Steve Gelsi

  3. New Teva CEO Richard Francis was CEO of Sandoz and Biogen exec

    7:05 a.m. Nov. 21, 2022

    - Steve Gelsi

  4. Teva CEO Kåre Schultz to retire on Dec. 31

    7:05 a.m. Nov. 21, 2022

    - Steve Gelsi

  5. Teva Pharmaceutical downgraded to underweight from neutral at J.P. Morgan

    6:45 a.m. Nov. 14, 2022

    - Tomi Kilgore

  6. Teva Is 'on the Way' to Leaving Opioid Litigation Behind, CEO Says

    11:28 a.m. Nov. 3, 2022

    - Barron's Online

  7. Teva Pharmaceutical upgraded to buy from neutral at BofA Securities

    8:44 a.m. Aug. 5, 2022

    - Tomi Kilgore

  8. $4.4 Billion Opioid Settlement Gives Teva Stock a Boost

    2:32 a.m. July 28, 2022

    - Barron's Online

  9. Teva Stock Soars After Reaching $4.25 Billion Opioid Settlement

    5:14 a.m. July 27, 2022

    - Barron's Online

  10. Teva to pay $75 mln over 15 years to settle opioid claims from W. Va., plus pay $8 mln in legal fees

    8:46 a.m. May 25, 2022

    - Steve Gelsi

  11. Teva settlement with W. Va. also includes $27 mln worth of generic Narcan over 10 years

    8:46 a.m. May 25, 2022

    - Steve Gelsi

  12. W. Va. says Teva opioid agreement consistent with previously announced settlements

    8:46 a.m. May 25, 2022

    - Steve Gelsi

  13. Teva Pharmaceutical upgraded to neutral from underperform at BofA Securities

    8:36 a.m. May 17, 2022

    - Tomi Kilgore

  14. Pfizer to Buy Biohaven Pharmaceuticals for $11.6 Billion

    9:06 a.m. May 10, 2022

    - Barron's Online

  15. Loading more headlines...

Analyst Ratings

/news/nonmarketwatch/company/us/teva

Other News on TEVA

  1. Teva Pharmaceutical Names Richard Francis as CEO

    10:13 a.m. Nov. 21, 2022

    - Colin Kellaher

  2. Opioid reversal agent naloxone approvable for OTC use – FDA

    1:37 p.m. Nov. 15, 2022

    - Seeking Alpha

  3. Top 5 3rd Quarter Trades of DSC Advisors, L.P.

    8:00 a.m. Nov. 15, 2022

    - GuruFocus.com

  4. Teva slips as JPMorgan downgrades on growth concerns

    9:01 a.m. Nov. 14, 2022

    - Seeking Alpha

  5. BECK MACK & OLIVER LLC Buys 2, Sells 3 in 3rd Quarter

    6:00 p.m. Nov. 10, 2022

    - GuruFocus.com

  6. Teva Pharmaceutical to Replace CEO Kare Schultz

    4:24 p.m. Nov. 3, 2022

    - Jared S. Hopkins

  7. 10-Q: TEVA PHARMACEUTICAL INDUSTRIES LTD

    4:22 p.m. Nov. 3, 2022

    - Edgar Online - (EDG = 10Q, 10K)

  8. Loading more headlines...
/news/pressrelease/company/us/teva

Press Releases on TEVA

  1. Teva Pharmaceutical (TEVA) Trading Report

    6:20 p.m. Nov. 26, 2022

    - Stock Traders Daily

  2. Teva Finalizes Nationwide Opioid Settlement Terms

    8:30 a.m. Nov. 22, 2022

    - BusinessWire - BZX

  3. Teva Announces Appointment of Richard Francis as President and CEO

    7:00 a.m. Nov. 21, 2022

    - BusinessWire - BZX

  4. Learn to Evaluate Teva Pharmaceutical (TEVA) using the Charts

    3:09 a.m. Nov. 17, 2022

    - Stock Traders Daily

  5. How To Trade Teva Pharmaceutical TEVA

    10:59 a.m. Nov. 7, 2022

    - Stock Traders Daily

  6. Teva Reports Third Quarter 2022 Financial Results

    6:00 a.m. Nov. 3, 2022

    - BusinessWire - BZX

  7. Teva Pharmaceutical TEVA Investment Report

    6:16 p.m. Oct. 28, 2022

    - Stock Traders Daily

  8. Teva Pharmaceutical TEVA Trading Report

    2:07 a.m. Oct. 19, 2022

    - Stock Traders Daily

  9. Teva Pharmaceutical TEVA Investment Analysis and Advice

    9:08 a.m. Oct. 9, 2022

    - Stock Traders Daily

  10. Loading more headlines...

Rates »

Link to MarketWatch's Slice.